Because fractional intestinal absorption remains unchanged at ∼60% in CKD, a usual intake of phosphorus in these patients will lead to phosphorus retention in the body with the subsequent increased risk of vascular calcifications, higher levels of PTH (less bone mass), and higher levels of FGF-23 (a cardiac toxin). Here, PTH is linked to chronic kidney disease.